Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1993-10-14
|
pubmed:abstractText |
The diagnostic work-up of renovascular hypertension is still controversial. The efficacy of renal scintigraphy with technetium-99m diethylene triamine pentaacetate (DTPA) before and after captopril (scintigraphic captopril test) was evaluated in a multicentre study. All 380 hypertensive patients in the study underwent renal arteriography; 125 had renal arterial stenosis > or = 70%, and 54 had a technically successful intervention to correct the stenosis. The post-captopril study had a sensitivity of 93% and a specificity of 100% for predicting blood pressure response to intervention, if renal function was normal and a combination of quantitative parameters was applied (individual kidney uptake index < 40%, time to peak activity < 2 min or > 10 min). In the entire population renal artery stenosis > or = 70% was detected with a sensitivity of 83% and a specificity of 93% if renal function was normal. In patients with abnormal renal function the performance of the test was worse, owing to a lower specificity which could be increased by using only time parameters. The performance of the test was optimal when the post-captopril findings were examined; no improvement was achieved by evaluation of the changes induced by captopril from the baseline. The test can thus be simplified by performing only a post-captopril study for routine use: a negative test would exclude a curable form of renovascular hypertension in > 80% and a positive test would predict it in > 90% of the patients selected for suspicion of the disease.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0340-6997
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
617-23
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8370384-Adult,
pubmed-meshheading:8370384-Captopril,
pubmed-meshheading:8370384-Europe,
pubmed-meshheading:8370384-Female,
pubmed-meshheading:8370384-Humans,
pubmed-meshheading:8370384-Hypertension, Renovascular,
pubmed-meshheading:8370384-Male,
pubmed-meshheading:8370384-Middle Aged,
pubmed-meshheading:8370384-Renal Artery Obstruction,
pubmed-meshheading:8370384-Sensitivity and Specificity,
pubmed-meshheading:8370384-Technetium Tc 99m Pentetate
|
pubmed:year |
1993
|
pubmed:articleTitle |
Captopril radionuclide test in renovascular hypertension: a European multicentre study. European Multicentre Study Group.
|
pubmed:affiliation |
Institute of Clinical Physiology, C.N.R., Multicentre Study Central Office, Pisa, Italy.
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|